ISSN: 2161-069X

Journal of Gastrointestinal & Digestive System
Open Access

Our Group organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

Open Access Journals gaining more Readers and Citations
700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ Readers

This Readership is 10 times more when compared to other Subscription Journals (Source: Google Analytics)

Mini Review

Economic Evaluation in Gastroenterology: The Brazilian Experience

Luciana Bertocco de Paiva Haddad*, Patrícia Coelho de Soárez, Luana Regina Baratelli Carelli Mendes and Luiz Augusto Carneiro D’Albuquerque

Department of Gastroenterology, University of Sao Paulo School of Medicine, Sao Paulo, Brazil

*Corresponding Author:
Luciana Bertocco de Paiva Haddad
Department of Gastroenterology
University of Sao Paulo School of Medicine
Sao Paulo, Brazil
Tel: 5511982116966
E-mail: luciana.haddad@hc.fm.usp.br

Received date: August 26, 2015 Accepted date: September 10, 2015 Published date: September 17, 2015

Citation: Haddad LBP, de Soárez PC, Mendes LRBC, D’Albuquerque LAC (2015) Economic Evaluation in Gastroenterology: The Brazilian Experience. J Gastrointest Dig Syst 5:338. doi:10.4172/2161-069X.1000338

Copyright: © 2015 Haddad LBP, et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.

Abstract

Health economic evaluations draw comparisons between and among alternative treatments, devices and health programs, in terms of their costs and benefits/consequences and such studies analyze data regarding clinical effectiveness, in relation to cost. Although most health economic evaluations examine only the direct costs of a technology—those related to medications, services and hospitalization—some take a broader approach, also evaluating the indirect costs—those related to lost productivity (on the part of the patients and caregivers), as well as to other aspects.

Keywords

Top